◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Fuso Pharmaceutical Industries,Ltd. (4538) Financial History

Name: Fuso Pharmaceutical Industries,Ltd. (4538) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Fuso Pharmaceutical Industries,Ltd. (4538) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Osaka, Japan. Its market capitalization is roughly JPY 19 billion. In the fiscal year ended 2026-03-31, 4538 reported JPY 62.3B in revenue and JPY 2.0B in net income.

Fuso Pharmaceutical Industries,Ltd. engages in the manufacture and sale of pharmaceuticals and medical equipment in Japan. The company offers injectable drugs and dialysis agents for artificial kidneys, as well as medical drugs and equipment.

Interactive charts & full statements →

4538 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 62.3B	JPY 60.6B	JPY 55.4B	JPY 51.0B
Gross Profit	JPY 16.0B	JPY 16.5B	JPY 13.8B	JPY 13.7B
Operating Income (EBIT)	JPY 2.6B	JPY 4.1B	JPY 2.0B	JPY 2.2B
Net Income	JPY 2.0B	(JPY 3.3B)	JPY 1.4B	JPY 1.6B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4538 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 734M)	(JPY 638M)	(JPY 645M)	(JPY 525M)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4538 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 90.3B	JPY 81.7B	JPY 75.8B	JPY 72.5B	—
Total Liabilities	JPY 55.3B	JPY 48.7B	JPY 39.1B	JPY 36.8B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4538 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

0867 · China Medical System Holdings Limited — $30 billion
1513 · Livzon Pharmaceutical Group Inc. — $23 billion
6887 · Sunshine Lake Pharma Co., Ltd. — $20 billion
0512 · Grand Pharmaceutical Group Limited — $19 billion
3933 · The United Laboratories International Holdings Limited — $18 billion
0013 · HUTCHMED (China) Limited — $17 billion
2929 · Pharma Foods International Co., Ltd. — $17 billion
2637 · Fujian Haixi Pharmaceuticals Co., Ltd. — $15 billion

← 4536 All “0-9” companies 4539 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.